Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3274183
Max Phase: Preclinical
Molecular Formula: C26H29Cl2N3O6
Molecular Weight: 434.37
Molecule Type: Small molecule
Associated Items:
ID: ALA3274183
Max Phase: Preclinical
Molecular Formula: C26H29Cl2N3O6
Molecular Weight: 434.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc(NC(C)CCCN)c2nc(OCc3ccc(Cl)cc3Cl)ccc2c1.O=C(O)/C=C\C(=O)O
Standard InChI: InChI=1S/C22H25Cl2N3O2.C4H4O4/c1-14(4-3-9-25)26-20-12-18(28-2)10-15-6-8-21(27-22(15)20)29-13-16-5-7-17(23)11-19(16)24;5-3(6)1-2-4(7)8/h5-8,10-12,14,26H,3-4,9,13,25H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-
Standard InChI Key: MSNOQLAEBDHGTF-BTJKTKAUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 434.37 | Molecular Weight (Monoisotopic): 433.1324 | AlogP: 5.67 | #Rotatable Bonds: 9 |
Polar Surface Area: 69.40 | Molecular Species: BASE | HBA: 5 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 10.20 | CX LogP: 5.01 | CX LogD: 2.41 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.45 | Np Likeness Score: -0.95 |
1. Shetty RV, Wetter WP, Blanton CD.. (1977) Synthesis of 2-benzyloxy and 2-benzylthio analogues of primaquine as potential antimalarials., 20 (10): [PMID:409843] [10.1021/jm00220a025] |
Source(1):